外科理论与实践 ›› 2018, Vol. 23 ›› Issue (06): 506-510.doi: 10.16139/j.1007-9610.2018.06.008

• 论著 • 上一篇    下一篇

腹腔镜胃袖状切除术对肥胖型多囊卵巢综合征代谢的影响(附33例报告)

马驰野, 朱江帆, 马颖璋, 满琳, 陆伟, 张启颖, 张亚丽   

  1. 同济大学附属东方医院糖尿病与减重外科,上海 200124
  • 收稿日期:2018-09-17 出版日期:2018-11-25 发布日期:2020-07-25
  • 通讯作者: 朱江帆,E-mail: zhujiangfan2005@163.com
  • 基金资助:
    中央高校基本科研业务费专项资金(22120180026)

Impact of laparoscopic sleeve gastrectomy on metabolism in obese patients with polycystic ovary syndrome: a report of 33 cases

MA Chiye, ZHU Jiangfan, MA Yingzhang, MAN Lin, LU Wei, ZHANG Qiying, ZHANG Yali   

  1. Department of Bariatric and Metabolic Surgery, East Hospital, Tongji University,Shanghai 200124, China
  • Received:2018-09-17 Online:2018-11-25 Published:2020-07-25

摘要: 目的: 探讨腹腔镜胃袖状切除术(laparoscopic sleeve gastrectomy, LSG)对肥胖型多囊卵巢综合征(polycystic ovary syndrome, PCOS)代谢改善的临床效果。方法: 回顾分析我院33例接受LSG的肥胖型PCOS病例临床资料和术后6个月内随访结果。术后3、6个月复查代谢指标变化。结果: 本研究PCOS病人平均年龄(27±5)岁,体质量指数(body mass index, BMI)均≥27.5,均伴月经紊乱或停经,按共识确诊为PCOS。术前BMI为(36.75±4.96),血清睾酮为(0.489±0.186) μg/L,促黄体素/促卵泡素(LH/FSH)为(1.72±0.90),胰岛素抵抗指数(HOMA-IR)为(14.14±16.79),糖化血红蛋白(HbA1c)为6.35 %±1.41 %。33例均顺利完成手术,无中转开腹和严重并发症发生。病人术后3、6个月BMI分别为(29.55±4.65)和(25.07±3.81),睾酮分别为(0.336±0.112) μg/L和(0.216±0.115) μg/L,LH/FSH分别为(1.68±1.08)和(1.28±0.95),HOMA-IR分别为(3.07±2.14)和(2.35±1.14),HbA1c分别为5.35%±0.40%和5.22%±0.30%。除LH/FSH(P>0.05)外,其他代谢指标术后3、6个月与术前差异均有统计学意义(P<0.05),且随时间延长呈下降趋势。术后3、6个月分别有11例(33.3%)和26(78.8%)月经紊乱情况得到缓解。术后3、6个月PCOS临床缓解率分别为51.5%(17例)和78.8%(26例)。结论: LSG可改善肥胖型PCOS病例的月经和排卵,缓解高雄激素血症等PCOS症状,其机制可能与胰岛素抵抗的减轻密切相关。

关键词: 胃袖状切除术, 多囊卵巢综合征, 肥胖症, 高雄激素血症, 胰岛素抵抗

Abstract: Objective To investigate the impact of laparoscopic sleeve gastrectomy (LSG) on metabolic improvement in obese patients with polycystic ovary syndrome(PCOS). Methods Thirty-three obese patients with PCOS who underwent LSG at our hospital were investigated retrospectively including clinical data and parameter changes in PCOS after 3 months and 6 months of follow-up. Results The average age of obese patients was (27±5) years and body mass index (BMI) all was ≥27.5. Patients had symptoms of menstrual disorders or amenorrhea and were diagnosed as PCOS according to Rotterdam ESHRE/ASRM-sponsored PCOS consensus. Preoperative BMI was (36.75±4.96), testosterone (TESTO) (0.489±0.186) μg/L, luteinizing hormone/follicle stimulating hormone (LH/FSH) (1.72±0.90), homeostatic model assessment-insulin resistance (HOMA-IR) (14.14±16.79) and glycosylated hemoglobin (HbA1c) 6.35 %±1.41 %. Operations were completed successfully without conversion to laparotomy and severe postoperative complications. Follow-up study showed that mean BMI was (29.55±4.65) at 3 months and (25.07±3.81) at 6 months postoperatively. Mean TESTO and LH/FSH were(0.336±0.112) μg/L and (1.68±1.08) at 3 months, (0.216±0.115) μg/L and (1.28±0.95) at 6 months postoperative respectively. Mean HOMA-IR was (3.07±2.14) and (2.35±1.14) at 3 months and 6 months follow-up, and HbA1c was 5.35%±0.40% and 5.22%±0.30%, respectively. The decrease in BMI, TESTO, FPG, HOMA-IR, peptide C, HbA1c, total cholesterol and triglyceride was found obviously at 3 months and 6 months postoperative compared to those preoperative with significant difference (P<0.05). The significant change in LH/FSH did not present at 3 months and 6 months after operation compared that before operation (P>0.05). At 3 months, 11 (33.3%) of 33 cases with menstrual disorders including amenorrhea were in clinical remission and 26 (78.8%) of 33 cases were at 6 months. PCOS in clinical remission was 17 (51.5%) of 33 cases at 3 months of follow-up and 26(78.8%) of 33 cases at 6 months. Conclusions LSG has a significant effect on menstrual disorder and hyperandrogenism in obesity patients with PCOS by the mechanism of improving insulin resistance.

Key words: Sleeve gastrectomy, Polycystic ovary syndrome, Obesity, Hyperandrogenism, Insulin resistance

中图分类号: